R. Huxley, S. Lewington, and R. Clarke, Cholesterol, Coronary Heart Disease and Stroke: A Review of Published Evidence from Observational Studies and Randomized Controlled Trials, Seminars in Vascular Medicine, vol.02, issue.3, pp.315-323, 2002.
DOI : 10.1055/s-2002-35402

R. Lozano, M. Naghavi, and K. Foreman, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, The Lancet, vol.380, issue.9859, pp.2095-2128, 2010.
DOI : 10.1016/S0140-6736(12)61728-0

URL : https://hal.archives-ouvertes.fr/hal-00827612

E. Jacobs and S. Gapstur, Cholesterol and Cancer: Answers and New Questions, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.11, pp.2805-2806, 2009.
DOI : 10.1158/1055-9965.EPI-09-1027

S. Silvente-poirot and M. Poirot, Cholesterol and Cancer, in the Balance, Science, vol.343, issue.6178, pp.1445-1446, 2014.
DOI : 10.1126/science.1252787

URL : https://hal.archives-ouvertes.fr/inserm-00968924

J. Ferlay, I. Soerjomataram, and R. Dikshit, Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-386, 2015.
DOI : 10.1002/ijc.29210

A. Von-eckardstein, M. Hersberger, and L. Rohrer, Current understanding of the metabolism and biological actions of HDL, Current Opinion in Clinical Nutrition and Metabolic Care, vol.8, issue.2, pp.147-152, 2005.
DOI : 10.1097/00075197-200503000-00007

C. Danilo and P. Frank, Cholesterol and breast cancer development, Current Opinion in Pharmacology, vol.12, issue.6, pp.677-682, 2012.
DOI : 10.1016/j.coph.2012.07.009

P. Sorlie and M. Feinleib, The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study, J Natl Cancer Inst, vol.69, issue.5, pp.989-996, 1982.

S. Silvente-poirot and M. Poirot, Cholesterol metabolism and cancer: the good, the bad and the ugly, Current Opinion in Pharmacology, vol.12, issue.6, pp.673-676, 2012.
DOI : 10.1016/j.coph.2012.10.004

URL : https://hal.archives-ouvertes.fr/inserm-00822284

J. Vilchez, A. Martinez-ruiz, N. Sancho-rodriguez, P. Martinez-hernandez, and J. Noguera-velasco, The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review, European Journal of Clinical Investigation, vol.86, issue.Suppl 3, pp.103-114, 2014.
DOI : 10.1111/eci.12185

M. Law and S. Thompson, Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies, Cancer Causes and Control, vol.115, issue.suppl 127, pp.253-261, 1991.
DOI : 10.1007/BF00052142

M. Touvier, P. Fassier, and M. His, Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies, British Journal of Nutrition, vol.2, issue.03, pp.347-357, 2015.
DOI : 10.1159/000227088

K. Esposito, P. Chiodini, and A. Capuano, Metabolic syndrome and postmenopausal breast cancer, Menopause, vol.20, issue.12, pp.1301-1309, 2013.
DOI : 10.1097/GME.0b013e31828ce95d

J. Melvin, L. Holmberg, S. Rohrmann, M. Loda, and M. Van-hemelrijck, Serum Lipid Profiles and Cancer Risk in the Context of Obesity: Four Meta-Analyses, Journal of Cancer Epidemiology, vol.3, issue.2, p.823849, 2013.
DOI : 10.1002/ijc.23191

L. Martin, O. Melnichouk, and E. Huszti, Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points, J Natl Cancer Inst, vol.107, issue.5, p.32, 2015.

H. Ni, H. Liu, R. Gao, L. Zelek, and M. Deschasaux, Serum lipids and breast cancer risk: a meta-analysis of prospective cohort studies Prospective associations between serum biomarkers of lipid metabolism and overall , breast and prostate cancer risk, PLoS ONE His M Eur J Epidemiol, vol.10, issue.292, pp.142669-17119, 2014.

J. Melvin, D. Seth, and L. Holmberg, Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study, Cancer Epidemiology Biomarkers & Prevention, vol.21, issue.8, pp.1381-1384, 2012.
DOI : 10.1158/1055-9965.EPI-12-0188

H. Ulmer, W. Borena, and K. Rapp, Serum triglyceride concentrations and cancer risk in a large cohort study in Austria, British Journal of Cancer, vol.50, issue.7, pp.1202-1206, 2009.
DOI : 10.1093/ije/27.5.794

L. Vatten and O. Foss, Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women, Cancer Res, vol.50, issue.8, pp.2341-2346, 1990.

T. Bjorge, A. Lukanova, and H. Jonsson, Metabolic Syndrome and Breast Cancer in the Me-Can (Metabolic Syndrome and Cancer) Project, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.7, pp.1737-1745, 2010.
DOI : 10.1158/1055-9965.EPI-10-0230

G. Kabat, M. Kim, and R. Chlebowski, A Longitudinal Study of the Metabolic Syndrome and Risk of Postmenopausal Breast Cancer, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.7, pp.2046-2053, 2009.
DOI : 10.1158/1055-9965.EPI-09-0235

C. Agnoli, F. Berrino, and C. Abagnato, Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case???control study, Nutrition, Metabolism and Cardiovascular Diseases, vol.20, issue.1, pp.41-48, 2010.
DOI : 10.1016/j.numecd.2009.02.006

A. Emaus, M. Veierod, and S. Tretli, Metabolic profile, physical activity, and mortality in breast cancer patients, Breast Cancer Research and Treatment, vol.111, issue.3, pp.651-660, 2010.
DOI : 10.1007/s10549-009-0603-y

S. Tornberg, L. Holm, J. Carstensen, and G. Eklund, Cancer Incidence and Cancer Mortality in Relation to Serum Cholesterol, JNCI Journal of the National Cancer Institute, vol.81, issue.24, pp.1917-1921, 1989.
DOI : 10.1093/jnci/81.24.1917

L. Vatten, O. Foss, and S. Kvinnsland, Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study, European Journal of Cancer and Clinical Oncology, vol.27, issue.5, pp.641-646, 1991.
DOI : 10.1016/0277-5379(91)90234-5

W. Wulaningsih, M. Vahdaninia, and M. Rowley, Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis, BMC Cancer, vol.121, issue.9, p.913, 2015.
DOI : 10.1186/s12885-015-1928-z

A. Furberg, M. Veierod, T. Wilsgaard, L. Bernstein, and I. Thune, Serum High-Density Lipoprotein Cholesterol, Metabolic Profile, and Breast Cancer Risk, JNCI Journal of the National Cancer Institute, vol.96, issue.15, pp.1152-1160, 2004.
DOI : 10.1093/jnci/djh216

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=

A. Kotronen, H. Yki-jarvinen, and K. Sevastianova, Comparison of the Relative Contributions of Intra-Abdominal and Liver Fat to Components of the Metabolic Syndrome, Obesity, vol.45, issue.1, pp.23-28, 2011.
DOI : 10.1152/ajpgi.00418.2003

F. Clavel-chapelon, Cohort Profile: The French E3N Cohort Study, International Journal of Epidemiology, vol.44, issue.3, pp.801-809, 2014.
DOI : 10.1093/ije/dyu184

M. His, G. Fagherazzi, S. Mesrine, M. Boutron-ruault, F. Clavel-chapelon et al., Pre-diagnostic body size and breast cancer survival in the E3N cohort study, Int J Cancer, 2016.

A. Kucharska-newton, W. Rosamond, P. Mink, A. Alberg, E. Shahar et al., HDL-Cholesterol and Incidence of Breast Cancer in the ARIC Cohort Study, Annals of Epidemiology, vol.18, issue.9, pp.671-677, 2008.
DOI : 10.1016/j.annepidem.2008.06.006

A. Eliassen, G. Colditz, B. Rosner, W. Willett, and S. Hankinson, Serum Lipids, Lipid-Lowering Drugs, and the Risk of Breast Cancer, Archives of Internal Medicine, vol.165, issue.19, pp.2264-2271, 2005.
DOI : 10.1001/archinte.165.19.2264

G. Fagherazzi, A. Fabre, M. Boutron-ruault, and F. Clavel-chapelon, Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort, European Journal of Cancer Prevention, vol.19, issue.2, pp.120-125, 2010.
DOI : 10.1097/CEJ.0b013e3283354918

A. Renehan, M. Zwahlen, and M. Egger, Adiposity and cancer risk: new mechanistic insights from epidemiology, Nature Reviews Cancer, vol.107, issue.8, pp.484-498, 2015.
DOI : 10.1038/nrc3967

P. Moorman, B. Hulka, and R. Hiatt, Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status, Cancer Epidemiol Biomarkers Prev, vol.7, issue.6, pp.483-488, 1998.

E. Esteve, W. Ricart, and J. Fernandez-real, Dyslipidemia and inflammation: an evolutionary conserved mechanism, Clinical Nutrition, vol.24, issue.1, pp.16-31, 2005.
DOI : 10.1016/j.clnu.2004.08.004